Trial Profile
Safety and Efficacy Study of a Eye Drop for Eye Allergy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Jun 2014
Price :
$35
*
At a glance
- Drugs Alcaftadine (Primary)
- Indications Allergic conjunctivitis
- Focus Registrational; Therapeutic Use
- Sponsors Vistakon Pharmaceuticals
- 24 Jun 2014 New trial record